Mirrored
Each row begins with the revision entry printed in a current DailyMed label.
← Data library
FDA label change dataset
The label has a history. Keep it visible.
Twenty dated entries across five labels, transcribed from each source document's Recent Major Changes section. Inspect the original, or take the structured data with you.
- Dated changes
- 20
- Source labels
- 05
- Coverage
- Aug 2025 – Jun 2026
- Last mirrored
- Aug 29, 2026
Collection coverage
A small dataset with inspectable edges.
This is not a claim to represent every FDA label. It is the complete revision ledger for the five originator labels currently in CareCanon's live GLP-1 collection.
How to read it
Source first, structure second.
Structured
CareCanon adds stable identifiers and fields for filtering, downloading and citation.
Bounded
A listed change is a document event, not an interpretation of clinical importance.
Source ledger
Every recorded entry
Newest first. Each source link opens the manufacturer label mirrored by DailyMed.
| Revised | Record | Section | Change named in label | Primary source |
|---|---|---|---|---|
| WEGOVYsemaglutide | 5.11 | Never Share WEGOVY FlexTouch Between Patients | DailyMed ↗ | |
| ZEPBOUNDtirzepatide | 5.2 | Warnings and Precautions Severe Gastrointestinal Adverse Reactions | DailyMed ↗ | |
| ZEPBOUNDtirzepatide | 2.4 | Dosage and Administration | DailyMed ↗ | |
| ZEPBOUNDtirzepatide | 5.10 | Never Share a ZEPBOUND KwikPen Between Patients | DailyMed ↗ | |
| MOUNJAROtirzepatide | 2.2 | Important Administration Instructions | DailyMed ↗ | |
| MOUNJAROtirzepatide | 5.10 | Never Share a MOUNJARO KwikPen Between Patients | DailyMed ↗ | |
| RYBELSUSsemaglutide | 2 | Dosage and Administration | DailyMed ↗ | |
| MOUNJAROtirzepatide | 1 | Indications and Usage | DailyMed ↗ | |
| MOUNJAROtirzepatide | 2.1 | Recommended Dosage | DailyMed ↗ | |
| MOUNJAROtirzepatide | 5.6 | Warnings and Precautions Severe Gastrointestinal Adverse Reactions | DailyMed ↗ | |
| WEGOVYsemaglutide | 5.6 | Severe Gastrointestinal Adverse Reactions | DailyMed ↗ | |
| OZEMPICsemaglutide | 5.7 | Warnings and Precautions, Severe Gastrointestinal Adverse Reactions | DailyMed ↗ | |
| RYBELSUSsemaglutide | 1 | Indications and Usage | DailyMed ↗ | |
| RYBELSUSsemaglutide | 5.2 | Warnings and Precautions Acute Pancreatitis | DailyMed ↗ | |
| RYBELSUSsemaglutide | 5.5 | Acute Kidney Injury Due to Volume Depletion | DailyMed ↗ | |
| RYBELSUSsemaglutide | 5.6 | Severe Gastrointestinal Adverse Reactions | DailyMed ↗ | |
| RYBELSUSsemaglutide | 5.8 | Acute Gallbladder Disease | DailyMed ↗ | |
| WEGOVYsemaglutide | 1 | Indications and Usage | DailyMed ↗ | |
| WEGOVYsemaglutide | 2 | Dosage and Administration | DailyMed ↗ | |
| WEGOVYsemaglutide | 5.5 | Warnings and Precautions, Acute Kidney Injury due to Volume Depletion | DailyMed ↗ |